Impact of number of lifetime antiseizure medications on 12-month effectiveness, quality of life and tolerability outcomes of adjunctive brivaracetam in patients with focal seizures: Post-hoc analysis of a real-world European study

被引：0

作者：

Leach, J. ^{[1
]}

Kelemen, A. ^{[2
]}

Doherty, C. ^{[3
,4
]}

Schulz, A. -L. ^{[5
]}

Brock, F. ^{[6
]}

Leunikava, I.

Bourikas, D. ^{[7
]}

Steinhoff, B. ^{[8
]}

机构：

[1] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland

[2] Natl Inst Clin Neurosci, Budapest, Hungary

[3] Trinity Coll Dublin, Dublin, Ireland

[4] RCSI, FutureNeuro, SFI Res Ctr, Dublin, Ireland

[5] UCB Pharma, Monheim, Germany

[6] UCB Pharma, Slough, Berks, England

[7] UCB Pharma, Alimos, Greece

[8] Kork Epilepsy Ctr, Kehl, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

309

引用

页码：64 / 64

页数：1

共 31 条